Switzerland covid-19 symptoms medicines patient Switzerland

Novartis offers non-profit medicines portfolio for Covid-19

Reading now: 903
www.pharmaceutical-technology.com

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Swiss pharmaceutical giant Novartis has launched a not-for-profit medicines portfolio to help treat Covid-19 symptoms in patients in low-income and lower-middle-income countries.

As the disease currently lacks vaccine or curative treatment, the company aims to offer affordable drugs to address the major symptoms.

Covid-19 patients are known to experience inflammation and respiratory problems that can result in severe complications and even death.

The Covid-19 portfolio by Novartis includes 15 medicines from its Sandoz unit for treating gastro-intestinal illness, acute respiratory symptoms, pneumonia and septic shock.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA